The market expects IQVIA Holdings (IQV) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on October 31, 2024, might help the stock move higher if these key numbe ...

IQVIA Holdings Inc. (IQV) has had an impressive run over the past three months. The stock has gained 9.3%, outperforming the 3.9% rise of the industry it belongs to and the Zacks S&P 500 composite's 2% uptick. IQV has an expected long-term (three to five years) EPS growth rate of 10.4%. The company's earnings for 2024 and 2025 are expected to grow 9.6% and 10.6%, respectively. IQV's Global Reach, Market Leadership in Healthcare Analytics IQVIA operates in over 100 countries, giving it a vast global footprin ...

IQVIA Holdings Inc. (IQV) had an impressive run in the past three months. The company's shares have gained 12.5% compared with the 3.4% rally of its industry and the 2.5% rise of the Zacks S&P 500 composite. IQV reported impressive second-quarter 2024 results. Adjusted earnings (excluding 67 cents from nonrecurring items) were $2.6 per share, outpacing the Zacks Consensus Estimate by 2.3% and increasing 2.4% on a year-over-year basis. Total revenues of $3.8 billion surpassed the consensus estimate marginall ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both. The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens. It also includes access to the Zacks Style Scores. What ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both. The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens. It also includes access to the Zacks Style Scores. What ...

PHILADELPHIA, Sept. 4, 2024 /PRNewswire/ -- Signant Health, the leader in evidence generation for modern clinical trials, announced today it has joined IQVIA, a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, in its One Home for Sites™ initiative. IQVIA One Home for Sites is an industry-wide collaboration designed to simplify site conduct when clinical research staff leverage multiple eClinical technologies from multiple solu ...

It has been about a month since the last earnings report for IQVIA Holdings (IQV) . Shares have added about 3.4% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to its next earnings release, or is IQVIA due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers. IQVIA Surpasses Q2 Earnings Estimates IQVIA Holdin ...

I I F ■ F Matteo Colombo Investment update Following my May publication on IQVIA Holdings Inc. (NYSE:IQV) the stock is +5%, marking a 28% return since I first rated the business investment-grade back in Jan '21. This is a business I know tremendously well, having analyzed its credentials for more than 3 years and owned the stock for our equity budget for that entire duration. In the five publications I've made on IQV here on SA since then, my views have not changed on this long-term compounder. Following it ...

Core Insights - IQVIA Holdings Inc. (IQV) shares have increased by 12% over the past year, outperforming the industry growth of 10% [1] - The company has a projected long-term EPS growth rate of 10.4%, with anticipated earnings growth of 9.5% for 2024 and 11% for 2025 [1] Financial Performance - The Technology & Analytics Solutions (TAS) segment saw a 4% revenue increase in Q2 2024, excluding COVID-19 impacts and foreign exchange effects, with expected TAS revenue growth of 6-7% for the second half of the year [2] - R&D Solutions (R&DS) recorded new bookings of approximately $2.7 billion and a record backlog of $30.6 billion, indicating strong future revenue potential [3] - Management expects total revenues for Q3 2024 to be between $3.83 billion and $3.88 billion, and for full-year 2024 to be in the range of $15.4 billion to $15.5 billion [4] - EPS for Q3 2024 is anticipated to range between $2.76 and $2.86 per share [4] Strategic Initiatives - The company is investing in AI and machine learning, leading to market-leading solutions that enhance operational efficiency and client engagement [5] - In Q2 2024, IQVIA contracted with a top 20 client to expand its commercial technology ecosystem, integrating AI and ML offerings into the client's infrastructure for better data management [6] Operational Challenges - The company faces challenges due to large pharmaceutical companies implementing cost-cutting measures, affecting pricing negotiations in both commercial and R&DS segments [6] - Operating expenses increased to $509 million in Q2 2024 from $482 million in Q2 2023, indicating rising costs [7] - The current ratio was 0.84 at the end of Q2 2024, suggesting potential difficulties in meeting short-term obligations [8]

In the current global economy, which is more interconnected than ever, a company's success in penetrating international markets is crucial for its financial health and growth journey. Investors must understand a company's dependence on overseas markets, as this offers a window into the company's earnings stability, its ability to benefit from varied economic cycles and its potential for long-term growth. Participation in global economies acts as a defense against economic difficulties at home and a pathway ...